甲改变了不匹配的修复,从而触发了瘤免疫性
Huanling Zhang1,2, Jiaxin Wu3, Lei Cui3
1Guangzhou Institute of Clinical Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, China. eyzhanghuanling@scut.edu.cn.
Oncogene
|January 15, 2025
概括
甲 (PYZ) 通过增加瘤免疫性来增强癌症免疫疗法. 这种FDA批准的药物激活STING信号,促进CD8+T细胞透,改善了对MMR熟练癌症的治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 不匹配修复缺陷 (dMMR) 癌症对免疫疗法反应良好,但MMR熟练 (pMMR) 癌症是一个挑战.
- 制定提高pMMR癌症免疫疗法疗效的策略至关重要.
研究的目的:
- 为了研究甲 (PYZ) 在增强pMMR癌症中的瘤免疫性和免疫疗法反应方面的潜力.
- 阐明PYZ调节瘤微环境和免疫反应的潜在机制.
主要方法:
- 利用PYZ诱导活性氧物种 (ROS),DNA损伤,并抑制不匹配修复 (MMR) 蛋白 (MSH2,MSH6).
- 在瘤模型中评估了STING通路激活,I型干扰素 (IFN-I) 信号和CD8+T细胞透.
- 在体内使用各种小鼠模型评估瘤生长抑制,包括裸体小鼠和 CD8+ T 细胞枯竭或 Ifnar 缺乏症的小鼠.
主要成果:
- PYZ的使用导致了DNA损伤的积累和STING通路的激活,增强了瘤免疫性.
- 刺激通路的激活对于PYZ诱导的IFN-I信号传递和抗瘤免疫是至关重要的.
- PYZ促进了CD8+T细胞的透,并抑制了瘤的生长,其作用取决于T细胞的存在和IFN-I信号.
结论:
- 甲 (PYZ) 通过降低MMR的调节和激活瘤细胞中的STING通路,有效触发瘤免疫性.
- PYZ提供了一种有希望的翻译方法,以改善MMR熟练癌症的免疫治疗结果.
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Nucleotide Excision Repair
3.4K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


